Evidence map›Paper›PMID 25932214›Full record

ArticleInternational journal of clinical and experimental medicine2015

The effect of polymorphism in DNA repair genes RAD51 and XRCC2 in colorectal cancer in Turkish population.

Suleyman Cetinkunar, Ilhami Gok, Ruchan Bahadir Celep, Dogan Ilhan, Hasan Erdem, Bulent Caglar Bilgin, Recep Aktimur

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis.The Journal of international medical research · 2021
    Pooled it
  2. Article
  3. XRCC2 Polymorphisms and Environmental Factors Predict High Risk of Colorectal Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Suleyman CetinkunarDepartment of General Surgery, Adana Numune Training and Research Hospital Adana, Turkey.
Ilhami GokDepartment of Bioengineering, Faculty of Engineering & Architecture, Kafkas University Kars Turkey.
Ruchan Bahadir CelepDepartment of General Surgery, Faculty of Medicine, Afyon Kocatepe University Afyonkarahisar, Turkey.
Dogan IlhanDepartment of Molecular Biology and Genetics, Faculty of Science & Literature, Kafkas University Kars, Turkey.
Hasan ErdemDepartment of General Surgery, Adana Numune Training and Research Hospital Adana, Turkey.
Bulent Caglar BilginDepartment of General Surgery, Faculty of Medicine, Kafkas University Kars, Turkey.
Recep AktimurDepartment of General Surgery, Samsun Training and Research Hospital Samsun, Turkey.
Kafkas University · TRAfyon Kocatepe University · TRSamsun University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genes RAD51 and XRCC2 encode proteins that are important for the repair of double-strand DNA breaks by recombination. Therefore, genetic variability in these genes may contribute to the occurrence and progression of carcinoma. We investigated the association of polymorphisms in the DNA repair genes XRCC2-A/G and RAD51-135G/C with the colorectal cancer risk. Genotypes were determined by PCR-RFLP assays in 71 patients with colorectal cancer and 86 age-matched healthy controls. After amplification, we used a restriction enzyme (RAD51; MvaI and XRCC2; HphI) and digested the PCR product. Then, this DNA fragments were passed through gel electrophoresis. By examining these images, we identified changes in the nucleotides in these specific regions. To clarify fragments polymorphisms, the PCR products were sequenced with an Applied Biosystems Automated Sequencer. We observed the Arg188His polymorphism of XRCC2 genes in 42.2%, as shown in 30 of the 71 cancer patients. Only 21 out of 86 controls showed this polymorphism (24.2%). We also observed that 21 of the 71 patients (29.5%) carried the RAD51135G/C polymorphism of this gene. The same polymorphism was observed in 11 of the 86 controls (12.7 %; p < 0.05). The obtained results indicate that the polymorphism of RAD51 and XRCC2 genes may be associated with the incidence of colon cancer in the Turkish population. Further studies, including those on a larger group of patients, are required to further clarify this point.

Indexed as

Colon cancerpolymorphismRAD51TurkeyXRCC2 genes

Identifiers

PMID25932214
PMCPMC4402861
OpenAlexW427794697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.